Medovate works with a range of organisations to identify and develop innovations in medical technology and encourage uptake to promote better patient outcomes.


Cambridge University Hospitals NHS Foundation Trust

One of the largest and most renowned NHS Trusts in the UK, care is delivered through Addenbrooke’s and The Rosie Hospitals in Cambridge. CUH is also a leading national centre for specialist treatment, a government-designated comprehensive biomedical research centre, one of only five academic health science centres in the UK, and a university teaching hospital with a worldwide reputation.


The Leeds Teaching Hospitals NHS Trust

Leeds Teaching Hospitals NHS Trust is one of the largest and busiest acute hospital trusts in the UK. Medovate is working with Leeds Teaching Hospitals to develop RADS, (Regional Anaesthesia Delivery System).


The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust

Providing a comprehensive range of specialist, acute, obstetrics and community-based services. Medovate is working with The Queen Elizabeth Hospital to develop SAFIRA, (Safer Injection For Regional Anaesthesia).


Health Enterprise East

Delivering technology advisory services and innovation management to industry and the NHS. Medovate works with HEE to identify new NHS created medical technology opportunities.


NVM Private Equity LLP

Independently owned with over 30 years’ experience of investing in unquoted UK businesses. NVM is an investor shareholder in Medovate.


Medtech Accelerator

Facilitating early stage development of medtech innovations that meet unmet clinical needs within the NHS. Medovate works with the MTA to identify new medical technology opportunities.